インスティル・バイオ
Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.63 | $0 | -$5M |
| 2026 Q1 | -0.62 | $0 | -$1M |
| 2025 Q4 | -1.21 | $0 | -$7M |
| 2025 Q3 | -2.01 | $0 | -$11M |
| 2025 Q2 | -3.24 | $0 | -$15M |
| 2025 Q1 | -4.32 | $0 | -$4M |
| 2024 Q4 |
| -1.82 |
| $0 |
| -$11M |
| 2024 Q3 | -3.54 | $0 | -$20M |